Eugenio Zoni
Eugenio Zoni
Home
Publications
Projects
Fun facts
Contact
BRCA2
Patient-derived xenografts and organoids model therapy response in prostate cancer
This proof-of-principle study provides a preclinical tool to screen drug responses to standard-of-care and newly identified, repurposed compounds.
Patient-derived xenografts and organoids model therapy response in prostate cancer
This proof-of-principle study provides a preclinical tool to screen drug responses to standard-of-care and newly identified, repurposed compounds.
Cite
×